Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Factors predicting active trea...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Factors predicting active treatment free-survival: 10-year experience of active surveillance

Factors predicting active treatment free-survival: 10-year experience of active surveillance

Bibliographic Details
Main Authors: M. Roscigno, F. Badenchini, M. Borghesi, V. Altieri, G. Cicchetti, P. Colombo, M. Colecchia, L.F. Da Pozzo, P. Ditonno, M. Fabiano, M. Fiorentino, A. Lapini, E. Frego, M. Gallucci, R. Montironi, G. Guazzoni, G. Napodano, B. Paolini, C. Patriarca, F. Pierconti, A. Ranieri, M. Tanello, T. Magnani, G. Conti, R. Valdagni
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320336351
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320336351

Similar Items

  • Factors predicting active treatment free-survival and initial experience with mpMRI as a selection tool in patient undergoing active surveillance: 10-year follow-up of SIUrO PRIAS-ITA working group
    by: M. Roscigno, et al.
    Published: (2020-10-01)
  • Physical activity decreases the risk of cancer progression in patients on active surveillance: A multicenter retrospective study
    by: A. Brassetti, et al.
    Published: (2020-07-01)
  • ADAR1 is highly expressed in primary prostate cancer and correlated with CD8+ T-lymphocytes density
    by: G. Taverna, et al.
    Published: (2020-10-01)
  • A predictive model to personalize follow up schedules for patients in active surveillance
    by: F. Badenchini, et al.
    Published: (2020-07-01)
  • Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
    by: D. Maffei, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs